Glycemic control and cancer outcomes in oncologic patients with diabetes: an Italian Association of Medical Oncology (AIOM), Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), Italian Society of Endocrinology (SIE), Italian Society of Pharmacology (SIF) multidisciplinary critical view
Journal of Endocrinological Investigation · 27.06.2024 · 47 (12) · 2915-2928
DOI: 10.1007/s40618-024-02417-z ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Endocrinological Investigation, online erschienen am 27.06.2024. Verfasst von A Natalicchio und 29 weiteren Autor:innen. Beteiligte Einrichtung: Department of Precision and Regenerative Medicine and Ionian Area, Section of Internal Medicine, Endocrinology, Andrology and Metabolic Diseases, Uni…. Hauptthemen laut MEDLINE: Glycemic Control, Neoplasms, Diabetes Mellitus. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 110 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Università degli Studi di Bari Aldo Moro.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Increasing evidence suggests that diabetes increases the risk of developing different types of cancer. Hyperinsulinemia, hyperglycemia and chronic inflammation, characteristic of diabetes, could represent possible mechanisms involved in cancer development in diabetic patients. At the same time, cancer increases the risk of developing new-onset diabetes, mainly caused by the use of specific anticancer therapies. Of note, diabetes has been associated with a ∼10% increase in mortality for all cancers in comparison with subjects who did not have diabetes. Diabetes is associated with a worse prognosis in patients with cancer, and more recent findings suggest a key role for poor glycemic control in this regard. Nevertheless, the association between glycemic control and cancer outcomes in oncologic patients with diabetes remains unsettled and poorly debated.
Purpose
The current review seeks to summarize the available evidence on the effect of glycemic control on cancer outcomes, as well as on the possibility that timely treatment of hyperglycemia and improved glycemic control in patients with cancer and diabetes may favorably affect cancer outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Precision and Regenerative Medicine and Ionian Area, Section of Internal Medicine, Endocrinology, Andrology and Metabolic Diseases, University of Bari Aldo Moro, Piazza Giulio Cesare, 11, I-70124, Bari, It…
- Department of Precision and Regenerative Medicine and Ionian Area, Section of Pharmacology, University of Bari Aldo Moro, Bari, Italy.
- Endocrinology and Metabolic Diseases Unit, Azienda Ospedaliero-Universitaria SS Antonio e Biagio e Cesare Arrigo of Alessandria, Alessandria, Italy.
- Endocrinology Unit, Department of Clinical & Molecular Medicine, Sant'Andrea Hospital, Sapienza University of Rome, Rome, Italy.
- Section of Endocrinology, Geriatrics and Internal Medicine, Department of Medical Sciences, University of Ferrara, Ferrara, Italy.
- Medical Oncology Unit, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.
Förderung
- Università degli Studi di Bari Aldo Moro
Zitieren
APA
Natalicchio, A., Marrano, N., Montagnani, M., Gallo, M., Faggiano, A., Zatelli, M. C., Argentiero, A., Del Re, M., D'Oronzo, S., Fogli, S., Franchina, T., Giuffrida, D., Gori, S., Ragni, A., Marino, G., Mazzilli, R., Monami, M., Morviducci, L., Renzelli, V., …, & Giorgino, F. (2024). Glycemic control and cancer outcomes in oncologic patients with diabetes: an Italian Association of Medical Oncology (AIOM), Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), Italian Society of Endocrinology (SIE), Italian Society of Pharmacology (SIF) multidisciplinary critical view. Journal of Endocrinological Investigation, 47(12), 2915-2928. https://doi.org/10.1007/s40618-024-02417-z
Vancouver
Natalicchio A, Marrano N, Montagnani M, Gallo M, Faggiano A, Zatelli MC, et al. Glycemic control and cancer outcomes in oncologic patients with diabetes: an Italian Association of Medical Oncology (AIOM), Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), Italian Society of Endocrinology (SIE), Italian Society of Pharmacology (SIF) multidisciplinary critical view. Journal of Endocrinological Investigation. 2024;47(12):2915-2928. doi:10.1007/s40618-024-02417-z
BibTeX
@article{Natalicchio2024,
author = {Natalicchio, A and Marrano, N and Montagnani, M and Gallo, M and Faggiano, A and Zatelli, M C and Argentiero, A and Del Re, M and D'Oronzo, S and Fogli, S and Franchina, T and Giuffrida, D and Gori, S and Ragni, A and Marino, G and Mazzilli, R and Monami, M and Morviducci, L and Renzelli, V and Russo, A and Sciacca, L and Tuveri, E and Cortellini, A and Di Maio, M and Candido, R and Perrone, F and Aimaretti, G and Avogaro, A and Silvestris, N and Giorgino, F},
title = {Glycemic control and cancer outcomes in oncologic patients with diabetes: an Italian Association of Medical Oncology (AIOM), Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), Italian Society of Endocrinology (SIE), Italian Society of Pharmacology (SIF) multidisciplinary critical view},
journal = {Journal of Endocrinological Investigation},
year = {2024},
volume = {47},
number = {12},
pages = {2915--2928},
doi = {10.1007/s40618-024-02417-z}
}
EUVIMED